Continuous spectrum of pharyngeal-cervical-brachial variant of Guillain-Barré syndrome

Archives of Neurology

Volumn 64, Issue 10, 2007, Pages 1519-1523

  Nagashima, Takahide ^a   Koga, Michiaki ^a   Odaka, Masaaki ^a   Hirata, Koichi ^a   Yuki, Nobuhiro ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARM WEAKNESS; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MUSCLE WEAKNESS; MYOTATIC REFLEX; NECK MUSCLE; PHARYNX DISEASE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER JEJUNI; CHILD; ENCEPHALITIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GANGLIOSIDES; GUILLAIN-BARRE SYNDROME; HUMANS; IMMUNOGLOBULIN G; INFECTION; MALE; MIDDLE AGED; MUSCLE WEAKNESS; NECK MUSCLES; NEUROLOGIC EXAMINATION; PHARYNGEAL MUSCLES; REFLEX, STRETCH; RETROSPECTIVE STUDIES; UPPER EXTREMITY;

EID: 35348858154     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.64.10.1519     Document Type: Article

References (27)

1. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol. 1990;27(suppl):S21-S24.
2. Fisher M. An unusual variant of acute idiopathic polyneuritis: syndrome of ophthalmoplegia, ataxia and areflexia. N Engl J Med. 1956;255(2):57-65.
3. Yuki N, Sato S, Tsuji S, Hozumi I, Miyatake T. An immunologic abnormality common to Bickerstaff's brain stem encephalitis and Fisher's syndrome. J Neurol Sci. 1993;118(1):83-87.
4. Ropper AH. Unusual clinical variants and signs in Guillain-Barré syndrome. Arch Neurol. 1986;43(11):1150-1152.
5. Ropper AH. Further regional variants of acute immune polyneuropathy. Arch Neurol. 1994;51(7):671-675.
6. Miura Y, Susuki K, Yuki N, Ayabe M, Shoji H. Guillain-Barré syndrome presenting pharyngeal-cervical-brachial weakness in the recovery phase [letter]. Eur Neurol. 2002;48(1):53-54.
7. Jacobs BC, Rothbarth PH, van der Meché FGA, et al. The spectrum of antecedent infections in Guillain-Barré syndrome: a case-control study. Neurology. 1998;51(4):1110-1115.
8. Koga M, Gilbert M, Li J, et al. Antecedent infections in Fisher syndrome: a common pathogenesis of molecular mimicry. Neurology. 2005;64(9):1605-1611.
9. Arai M, Susuki K, Koga M. Axonal pharyngeal-cervical-brachial variant of Guillain-Barré syndrome without anti-GT1a IgG antibody. Muscle Nerve. 2003;28(2):246-250.
10. Ogawara K, Kuwabara S, Mori M, Hattori T, Koga M, Yuki N. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan. Ann Neurol. 2000;48(4):624-631.
11. Ogawara K, Kuwabara S, Koga M, Mori M, Yuki N, Hattori T. Anti-GM1b IgG antibody is associated with acute motor axonal neuropathy and Campylobacter jejuni infection. J Neurol Sci. 2003;210(1-2):41-45.
12. Okuda B, Koga M, Katsuta T, Okamoto K, Yuki N. Fulminant Guillain-Barré syndrome after Campylobacter jejuni enteritis and monospecific anti-GT1a IgG antibody. Intern Med. 2002;41(10):889-891.
13. Chiba A, Kusunoki S, Obata H, Machinami R, Kanazawa I. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies. Neurology. 1993;43(10):1911-1917.
14. Mizoguchi K, Hase A, Obi T, et al. Two species of antiganglioside antibodies in a patient with a pharyngeal-cervical-brachial variant of Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry. 1994;57(9):1121-1123.
15. Koga M, Yuki N, Ariga T, Morimatsu M, Hirata K. Is IgG anti-GT1a antibody associated with pharyngeal-cervical-brachial weakness or oropharyngeal palsy in Guillain-Barré syndrome? J Neuroimmunol. 1998;86(1):74-79.
16. Kashihara K, Shiro Y, Koga M, Yuki N. IgG Anti-GT1a antibodies which do not cross react with GQ1b ganglioside in a pharyngeal-cervical-brachial variant of Guillain-Barré syndrome [letter]. J Neurol Neurosurg Psychiatry. 1998;65(5):799.
17. Bickerstaff ER. Brain-stem encephalitis: further observations on a grave syndrome with benign prognosis. Br Med J. 1957;1(5032):1384-1387.
18. Nagashima T, Koga M, Odaka M, Hirata K, Yuki N. Clinical correlates of serum anti-GT1a IgG antibodies. J Neurol Sci. 2004;219(1-2):139-145.
19. Yuki N, Tagawa Y, Irie F, Hirabayashi Y, Handa S. Close association of Guillain-Barré syndrome with antibodies to minor monosialogangliosides GM1b andGM1-α. J Neuroimmunol. 1997;74(1-2):30-34.
20. Tagawa Y, Yuki N, Hirata K. High anti-GM1 and anti-GD1a IgG antibody titers are detected in Guillain-Barré syndrome but not in chronic inflammatory demyelinating polyneuropathy [letter]. Eur Neurol. 2002;48(2):118-119.
21. Koga M, Yoshino H, Morimatsu M, Yuki N. Anti-GT1a IgG in Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry. 2002;72(6):767-771.
22. Ropper AH, Wijdicks EFM, Truax BT. Guillain-Barré Syndrome. Philadelphia, PA: FA Davis Co Publishers; 1991.
23. van der Meché FGA, van Doorn PA, Meulstee J, Jennekens FGI. Diagnostic and classification criteria for the Guillain-Barré syndrome. Eur Neurol. 2001;45(3):133-139.
24. ter Bruggen JP, van der Meché FGA, de Jager AEJ, Polman CH. Ophthalmoplegic and lower cranial nerve variants merge into each other and into classical Guillain-Barré syndrome. Muscle Nerve. 1998;21(2):239-242.
25. Yuki N, Hirata K. Preserved tendon reflexes in Campylobacter neuropathy [letter]. Ann Neurol. 1998;43(4):546-547.
26. Murakami N, Tomita Y, Koga M, et al. An adolescent with pharyngeal-cervicalbrachial variant of Guillain-Barré syndrome after cytomegalovirus infection [published online ahead of print December 20, 2005]. Brain Dev. 2006;28(4):269-271. doi:10.1016/j.braindev.2005.08.004.
27. Koga M, Takahashi M, Li J, Koike S, Hirata K, Yuki N. Comprehensive analysis of bacterial risk factors for developing Guillain-Barré syndrome after Campylobacter jejuni enteritis [published online ahead of print January 19, 2006]. J Infect Dis. 2006;193(4):547-555. doi:10.1086/499969.